Long-term survival following aortic valve replacement

Area of Science:

• Cardiology
• Cardiac Surgery
• Medical Outcomes

Background:

• Aortic valve replacement (AVR) is a critical procedure for severe aortic valve disease.
• Early AVR outcomes data are essential for understanding long-term patient prognosis.
• This study examines survival in patients from the initial phase of AVR implementation.

Purpose of the Study:

• To evaluate long-term survival and prognostic factors in patients who underwent aortic valve replacement between 1964 and 1970.
• To identify predictors of mortality and morbidity in early AVR survivors.
• To assess the influence of preoperative valve disease and hemodynamic parameters on survival.

Main Methods:

• Retrospective analysis of 95 patients surviving aortic valve replacement (1964-1970).
• Average follow-up duration of 50.2 months.
• Correlation of survival with hemodynamic parameters, preoperative valve type, angina, New York Heart Association (NYHA) class, and coronary artery disease.

Main Results:

• Survival was not significantly related to hemodynamic parameters (cardiac index, left ventricular pressure) or preoperative valve lesion type.
• History of angina pectoris and NYHA Class IV were associated with reduced survival.
• Coronary artery disease was a primary cause of death within 2 years; angina was the leading cause of long-term morbidity.
• Five patients experienced sudden death.
• Patients surviving 36 months post-AVR demonstrated excellent long-term prognosis.

Conclusions:

• Early aortic valve replacement outcomes were strongly influenced by patient-reported symptoms and functional class, not solely by objective hemodynamic measures.
• Long-term survival following AVR is favorable, particularly after the initial 3-year period, provided critical comorbidities are managed.
• Angina and associated coronary artery disease represent significant challenges for both early and late AVR survivors, highlighting the need for comprehensive cardiovascular care.